Website and social media enquiries

For all website and social media enquiries

Suzanne Bailey (Monday - Thursday)
T: 01923 779555
E: [email protected]

Gemma Marks (Friday)
T: 01923 779555
E: gemma @cureparkinsons.org.uk

Latest

The Cure Parkinson's 2021 Raid Series

Following the immense success last year’s Raid Pyrenean and this year’s virtual Raid Local event, we are excited to announce the Cure Parkinson’s 2021 Raid Series.
Raid Alpine 2021

Raid Alpine is a must for any committed cyclist. Departing from the beautiful shores of Lake Geneva and finishing in the stunning Mediterranean town of Nice, this ride boasts fantastic views and iconic climbs including Col de l’Iseran and the Cime de la Bonette.
Raid Pyrenean 2021

Raid Pyrenean is a phenomenal challenge for any road cycling enthusiast and is the ultimate time challenge. You will have just 100 hours to complete this epic traverse from the Atlantic to the Mediterranean across the stunning Pyrenees tackling some of the most famous cols it has to offer.
Raid Ventoux 2021

The most flexible of all the European Raids that CPT has to offer, Raid Ventoux allows you to choose from a series of rides including the infamous Ventoux Club des Cinglés Challenge.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more